20 results
6-K
EX-10.1
ENLV
Enlivex Therapeutics Ltd
30 Dec 22
Report of Foreign Private Issuer
4:02pm
Pharmaceutical Product, (ii) withdraws its approval of, requests the recall, suspension, or seizure of, or withdraws or orders the withdrawal
6-K
EX-1.1
ENLV
Enlivex Therapeutics Ltd
12 Feb 21
Enlivex Announces Closing of Previously Announced Bought Deal Offering of Approximately $46.0 Million Ordinary Shares
5:17pm
of, the testing of, the sale of, or the labeling and promotion of any Pharmaceutical Product, (ii) withdraws its approval of, requests the recall
6-K
EX-10.1
u3i qrketkgnyg
22 Oct 20
Report of Foreign Private Issuer
8:47am
6-K
EX-1.1
3u1e76kpyoi1it 71
5 Mar 20
Report of Foreign Private Issuer
8:16am
6-K
EX-1.1
0nnjepz
26 Feb 20
Enlivex Therapeutics Closes $8.0 Million Registered Direct Offering
4:15pm
20-F/A
21n x06ql
23 Jan 20
Annual report (foreign) (amended)
4:31pm
6-K
EX-99.1
7x0g473p41nedcg
19 Feb 19
Asset Purchase Agreement
4:57pm
6-K
EX-99.2
1u000ngqc7v sd
6 Dec 18
Amended Notice of Annual and Extraordinary General Meeting of the Shareholders
4:43pm
6-K
EX-99.1
7reh xavt6
19 Nov 18
Agreement and Plan of Merger
4:34pm
20-F
9ykl 912z21jfg2p6i
31 Mar 15
Annual report (foreign)
12:00am
424B4
2v6ipm
31 Jul 14
Prospectus supplement with pricing info
12:00am
F-1/A
bq1obou3
8 Jul 14
Registration statement (foreign) (amended)
12:00am
- Prev
- 1
- Next